Nasciutti LE

No ORCID on file · 19 papers in corpus · active 2007-2022

Study types

  • article 11
  • other 5
  • preprint 1

Condition tags

  • endometriosis 17
  • infertility 2
  • die_deep_infiltrating 2
  • dysmenorrhea 1
  • chronic_pelvic_pain 1
  • dyspareunia 1
article 2022
Pharmaceuticals (Basel, Switzerland) ·doi:10.3390/ph15111414

BACKGROUND: Current drugs for the treatment of endometriosis are not able to completely cure the condition, and significant side effects hinder the continuation of treatment. Therefore, it is necessary to search for new drug candidates. In …

preprint 2022
·doi:10.20944/preprints202210.0219.v1

Background: Current drug for the treatment of endometriosis is not able of completely cure and significant side effects hinder the continuation of treatment. So, the search for new drug candidates is necessary, and the use of plants extract…

article 2020
Reproduction (Cambridge, England) ·doi:10.1530/rep-19-0502

This study aimed to analyse the effects of clotrimazole (CTZ) on estrogen production pathway in endometriosis progression. Experimental endometriosis was induced by autologous transplantation in female Wistar rats, and then the rats were tr…

article 2019
Molecular and cellular endocrinology ·doi:10.1016/j.mce.2019.02.007

This study aimed to analyze galectin-3 importance in endometriotic lesions development and the effect of recombinant Gal-3 carbohydrate recognition domain (Gal3C) in experimental endometriosis treatment. Experimental endometriosis was induc…

2018
PloS one ·doi:10.1371/journal.pone.0200101

Cancer is an increasingly frequent malignancy worldwide, and despite the advances in drug development, it is still necessary to develop new plant-derived medicines. Euterpe oleracea (açaí) is abundant in South and Central America and has he…

other 2018
Molecular and cellular endocrinology ·doi:10.1016/j.mce.2018.04.005

The present work aimed to evaluate molecular, angiogenic and inflammatory changes induced by clotrimazole (CTZ) on endometriosis lesions. For this, thirty female Wistar rats with surgically implanted autologous endometrium were treated with…

other 2018
Pharmaceutical development and technology ·doi:10.1080/10837450.2017.1290107

Copaiba oleoresin (CPO), obtained from Copaifera landgroffii, is described as active to a large number of diseases and more recently in the endometriosis treatment. In this work, poly(lactic-co-glycolic acid) (PLGA) nanoparticles containing…

2018
BMC complementary and alternative medicine ·doi:10.1186/s12906-018-2183-z

BackgroundAmong the processes involved in the breast tumor microenvironment, angiogenesis and inflammation play a central role, and the main factors of these processes are the vascular endothelial growth factor (VEGF), cyclooxygenase 2 (COX…

article 2017
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2017.10.027

ObjectiveTo investigate the contribution of CYP2C19 polymorphisms and body mass index (BMI) in the development of endometriosis.Study designThis is a case-control study that includes 356 women (187 cases and 169 controls) recruited from two…

article 2016
Histology and histopathology ·doi:10.14670/hh-11-730

Endometriosis is a benign gynecological disease affecting approximately 10-15% of women of reproductive age and 25-50% of all infertile women. It is characterized by the presence of glands and/or endometrial stroma outside the uterine cavit…

article 2016
Materials science & engineering. C, Materials for biological applications ·doi:10.1016/j.msec.2016.03.094

In this work, newly developed nanocomposites based upon lamellar silicates are evaluated to determine their potential in controlling endometriosis. The preparation of the new nanocarriers is detailed, properties characterized and in vitro p…

other 2016
PloS one ·doi:10.1371/journal.pone.0166059

This study investigated the therapeutic potential of Euterpe oleracea extract (açaí) on the growth and survival of endometriotic lesions using an experimental model. Twenty female Sprague-Dawley rats were randomized into two groups after th…

article 2015
The Journal of pharmacy and pharmacology ·doi:10.1111/jphp.12479

OBJECTIVES: The hormonal treatment for endometriosis frequently fails to completely eradicate endometriotic implants. A new therapeutic treatment is needed. This study investigates the in-vitro effect of Copaifera langsdorffii oil-resin on …

article 2014
Histology and histopathology ·doi:10.14670/hh-29.903

Endometriosis involves the growth of endometriotic tissue outside the uterine cavity, and is frequently associated with different malignancies. A well-reported alteration in the disease microenvironment is the proliferation of new blood ves…

article 2014
BMC women's health ·doi:10.1186/1472-6874-14-117

BACKGROUND: Endometriosis is regarded as a complex and heterogeneous disease in which genetic and environmental factors contribute to the phenotype. The Vascular Endothelial Growth Factor (VEGF) plays important roles in the pathogenesis of …

other 2010
Fertility and sterility ·doi:10.1016/j.fertnstert.2009.11.037

OBJECTIVE: To analyze the antiangiogenic effects of the selective cyclooxygenase-2 (COX-2) inhibitor parecoxib on the growth of endometrial implants in a rat model of peritoneal endometriosis. DESIGN: Pharmacologic interventions in an expe…

article 2010
Journal of experimental & clinical cancer research : CR ·doi:10.1186/1756-9966-29-4

BACKGROUND: Endometriosis is a common disease characterized by the presence of a functional endometrium outside the uterine cavity, causing pelvic pain, dysmenorrheal, and infertility. This disease has been associated to development of diff…

other 2009
Micron (Oxford, England : 1993) ·doi:10.1016/j.micron.2009.02.005

The composition of sulfated glycosaminoglycans (GAGs) and the tissue distribution of chondroitin sulfate (CS) were analyzed in deeply infiltrating endometriosis (DIE) of rectosigmoid, using metachromatic staining, and biochemical analysis e…

article 2007
Fertility and sterility ·doi:10.1016/j.fertnstert.2007.05.076

ObjectiveTo analyze vascular density and immunolocalization of angiogenic vascular endothelial growth factor (VEGF) and its receptor Flk-1 in the proliferative and secretory eutopic human endometrium and in three different sites of endometr…